Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;44(2):297-305.
doi: 10.1007/s00246-022-03024-6. Epub 2022 Oct 18.

Octreotide for Acquired Chylothorax in Pediatric Patients Post-Cardiothoracic Surgery for Congenital Heart Disease: A Systematic Review

A C Jenkinson  1 , J McGuinness  2 , T Prendiville  3   4
Affiliations

Octreotide for Acquired Chylothorax in Pediatric Patients Post-Cardiothoracic Surgery for Congenital Heart Disease: A Systematic Review

A C Jenkinson et al. Pediatr Cardiol. 2023 Feb.

Abstract

Chylothorax is a life-threatening complication post-corrective congenital heart surgery. Octreotide is used for treatment of refractory chylothoraces, with no standardized treatment protocol and a paucity of literature describing its efficacy. Our aim was to provide an update on the safety and efficacy of octreotide for the treatment of refractory chylothoraces in neonatal and pediatric patients' post-corrective congenital heart surgery. We performed a systematic review of PubMed, Medline, CINAHL, and Cochrane Library databases. Only intravenous octreotide treatment was included. A total of 621 patients across 27 studies were included. Studies included were 11 case series, 5 case studies, and 11 retrospective cohort studies. Variation in treatment regimens were reported. Treatment efficacy was reported in 95% (23/27) of studies. Definitions of treatment efficacy were reported in 33% (9/27) of studies. No prospective or randomized control trials were available for inclusion. Octreotide efficacy is widely reported despite a lack of standardization on criteria for treatment initiation or what defines an appropriate response to therapy.Please check and confirm whether the edit made to the article title is in order.Yes.

Keywords: Chylothorax; Neonatal; Octreotide; Pediatric.

PubMed Disclaimer

References

    1. Bellini C et al (2013) Dynamics of pleural fluid effusion and chylothorax in the fetus and newborn: role of the lymphatic system. Lymphology 46(2):75–84
    1. Bellini C et al (2012) Congenital fetal and neonatal visceral chylous effusions: neonatal chylothorax and chylous ascites revisited. A multicenter retrospective study. Lymphology 45(3):91–102
    1. Biewer ES et al (2010) Chylothorax after surgery on congenital heart disease in newborns and infants -risk factors and efficacy of MCT-diet. J Cardiothorac Surg 5(1):127 - DOI
    1. Rosti L et al (2005) Octreotide in the management of postoperative chylothorax. Pediatr Cardiol 26(4):440–443 - DOI
    1. Panthongviriyakul C, Bines JE (2008) Post-operative chylothorax in children: an evidence-based management algorithm. J Paediatr Child Health 44(12):716–721 - DOI

Publication types

LinkOut - more resources